Combined Treatment of Photodynamic Therapy and Bevacizumab for Choroidal Neovascularization Secondary to Age-Related Macular Degeneration-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Combined Treatment of Photodynamic Therapy and Bevacizumab for Choroidal Neovascularization Secondary to Age-Related Macular Degeneration

Published:2011 Issue:4 Volume:25 Page:231
ISSN:1011-8942
Container-title:Korean Journal of Ophthalmology
language:en
Short-container-title:Korean J Ophthalmol

Author:

Kim Hyun Woong¹,Kim Jung Lim¹,Lee Mi Hyun²,Yoo Hyung Gon³,Chung In Young⁴,Lee Ji Eun²

Affiliation:

1. Department of Ophthalmology, Inje University College of Medicine, Busan, Korea.

2. Department of Ophthalmology, Pusan National University School of Medicine, Yangsan, Korea.

3. Department of Ophthalmology, Seoul National University College of Medicine, Seoul, Korea.

4. Department of Ophthalmology, Gyeongsang National University School of Medicine, Jinju, Korea.

Publisher

Korean Ophthalmological Society

Subject

General Medicine

Link

https://synapse.koreamed.org/pdf/10.3341/kjo.2011.25.4.231

Reference31 articles.

1. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization—verteporfin in photodynamic therapy report 2

2. Verteporfin Therapy of Subfoveal Minimally Classic Choroidal Neovascularization in Age-Related Macular Degeneration

3. Expression of pigment epithelium derived factor and vascular endothelial growth factor in choroidal neovascular membranes and polypoidal choroidal vasculopathy

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of ranibizumab combined with photodynamic therapy on wet age‑related macular degeneration;Experimental and Therapeutic Medicine;2020-04-02

2. Combination of bevacizumab and photodynamic therapy vs. bevacizumab monotherapy for the treatment of wet age‑related macular degeneration: A meta‑analysis of randomized controlled trials;Experimental and Therapeutic Medicine;2018-06-13

3. Treatment of retinal pigment epithelial detachment secondary to exudative age-related macular degeneration;American Journal of Ophthalmology Case Reports;2018-03

4. Five-year Outcomes of Ranibizumab in Neovascular Age-related Macular Degeneration: Real Life Clinical Experience;Korean Journal of Ophthalmology;2017

5. Age-related macular degeneration and polypoidal choroidal vasculopathy in Asians;Progress in Retinal and Eye Research;2016-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3